Doug's Daily Diary

Celebrating Early

Stephen Guilfoyle's Latest Post

Options Profits/AAO

Technical Corner

Featured Commentary

More Trading Strategies

Stop Wishing, Hoping and Praying and Take Control of Your Investing

The most powerful thing an investor can do is embrace the idea that they don't know what the future holds.

Welcome to Second Semester on Wall Street, Here's How to Make the Grade

Think you can own big tech? You might just get an 'F' for that. Here's what will get you on the other side of this year.

We Got a Break, but the Heat Is Still On

A limited rally cooled some of the negativity on the market, but guess what's going to hit the fan soon?

Coupang Could Make a Bigger Trading Bounce

Here's where nimble traders could probe the long side.

Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?

Let's check the charts on this biotechnology stock and see if it still has a prayer.

Shares of Xencor Could Be Bought on a 50% Correction

Traders should remain patient.

In an Ugly First Half for Stocks, Value Was a Lot Less Ugly Than Growth

A look at the Russell indexes shows that value stocks suffered in the first six months of 2022 but not nearly as much as growth issues.

Nuvalent Has Begun the Bottoming Process

Let's check the charts and indicators.

You Can Invest in Micron, But Here's Why You May Want to Wait

MU reported earnings Thursday night and the guidance was shocking.

Enanta Pharmaceuticals Bounces Off a Key Support Level Once Again

The shares of the biotech company appear to be finding a bottom but could use more sideways action to create a better base.

UPGRADES & DOWNGRADES